CY1117948T1 - Μεθοδος επαγωγης ανοχης σε ενα αλλεργιογονο - Google Patents

Μεθοδος επαγωγης ανοχης σε ενα αλλεργιογονο

Info

Publication number
CY1117948T1
CY1117948T1 CY20161100750T CY161100750T CY1117948T1 CY 1117948 T1 CY1117948 T1 CY 1117948T1 CY 20161100750 T CY20161100750 T CY 20161100750T CY 161100750 T CY161100750 T CY 161100750T CY 1117948 T1 CY1117948 T1 CY 1117948T1
Authority
CY
Cyprus
Prior art keywords
inducing tolerance
allergyogen
present
allergy
subject
Prior art date
Application number
CY20161100750T
Other languages
English (en)
Inventor
Mimi Lai-Kuan Tang
Original Assignee
Murdoch Childrens Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40913317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1117948(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2008900463A external-priority patent/AU2008900463A0/en
Application filed by Murdoch Childrens Research Institute filed Critical Murdoch Childrens Research Institute
Publication of CY1117948T1 publication Critical patent/CY1117948T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται γενικά με τον τομέα των αλλεργιών. Πιο συγκεκριμένα, η παρούσα εφεύρεση παρέχει μία μέθοδο για τη θεραπεία μιας αλλεργίας σε ένα υποκείμενο μέσω της επαγωγής ανοχής σε ένα αλλεργιογόνο που σχετίζεται με την αλλεργία. Ιατρικά κιτ χρήσιμα σε πρωτόκολλα για την επαγωγή ανοχής ή τη μείωση της δυσανοχής σε ένα υποκείμενο αποτελούν επίσης μέρος της παρούσας εφεύρεσης.
CY20161100750T 2008-02-01 2016-07-29 Μεθοδος επαγωγης ανοχης σε ενα αλλεργιογονο CY1117948T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2008900463A AU2008900463A0 (en) 2008-02-01 A method of inducing tolerance to an allergen
PCT/AU2009/000104 WO2009094717A2 (en) 2008-02-01 2009-01-30 A method of inducing tolerance to an allergen

Publications (1)

Publication Number Publication Date
CY1117948T1 true CY1117948T1 (el) 2017-05-17

Family

ID=40913317

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100750T CY1117948T1 (el) 2008-02-01 2016-07-29 Μεθοδος επαγωγης ανοχης σε ενα αλλεργιογονο

Country Status (14)

Country Link
US (5) US9402896B2 (el)
EP (2) EP3097927B1 (el)
AU (1) AU2009208390B2 (el)
CY (1) CY1117948T1 (el)
DK (1) DK2244734T3 (el)
ES (2) ES2585407T3 (el)
HR (1) HRP20160945T1 (el)
HU (1) HUE029000T2 (el)
LT (1) LT2244734T (el)
NZ (1) NZ587137A (el)
PL (1) PL2244734T3 (el)
PT (1) PT2244734T (el)
SI (1) SI2244734T1 (el)
WO (1) WO2009094717A2 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2244734T3 (en) * 2008-02-01 2016-08-15 Murdoch Childrens Res Inst PROCEDURE FOR INDUCTION OF TOLERANCE ABOUT AN ALLERGY
IN2014MN01513A (el) * 2012-02-07 2015-09-11 Jolla Inst Allergy Immunolog
DE102012101864A1 (de) * 2012-03-06 2013-09-12 Gramme-Revit Gmbh Mittel zur Behandlung von Allergien und anderen Erkrankungen
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CN114129720A (zh) 2015-02-20 2022-03-04 斯坦福大学托管董事会 混合变应原组合物及其使用方法
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
EP3654778A1 (en) 2017-07-18 2020-05-27 Before Brands, Inc. Methods for making mixed allergen compositions
CN111629721A (zh) 2017-12-06 2020-09-04 百乐吉公司 用于减少过敏反应的组合物和方法
JP2022519817A (ja) 2019-01-23 2022-03-25 ビフォー ブランズ，インコーポレイテッド 混合アレルゲン組成物の製造方法
JP2023506423A (ja) * 2019-12-23 2023-02-16 プロタ セラピューティクス ピーティワイ リミテッド アレルギー治療

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
AUPQ415899A0 (en) 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
JP2004527450A (ja) 2000-04-06 2004-09-09 シーア ファーマスーティカルズ エルエルシー 微生物送達システム
US7060687B2 (en) 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
AU2005316041B2 (en) * 2004-12-14 2010-06-24 Alk Abello A/S Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound
US20060233772A1 (en) 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
EP1723965A1 (en) * 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
WO2007051476A1 (en) * 2005-11-04 2007-05-10 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
EP2010645A4 (en) * 2006-04-20 2009-05-06 Univ Singapore RECOMBINANT LACTOBACILLUS AND USE THEREOF
DK2244734T3 (en) * 2008-02-01 2016-08-15 Murdoch Childrens Res Inst PROCEDURE FOR INDUCTION OF TOLERANCE ABOUT AN ALLERGY

Also Published As

Publication number Publication date
EP2244734B1 (en) 2016-05-04
EP2244734A2 (en) 2010-11-03
US20190070288A1 (en) 2019-03-07
US9402896B2 (en) 2016-08-02
AU2009208390B2 (en) 2014-07-17
EP3097927A1 (en) 2016-11-30
US20200197515A1 (en) 2020-06-25
AU2009208390A1 (en) 2009-08-06
NZ587137A (en) 2013-02-22
US10071157B2 (en) 2018-09-11
EP3097927B1 (en) 2023-05-03
WO2009094717A2 (en) 2009-08-06
HUE029000T2 (en) 2017-02-28
WO2009094717A3 (en) 2010-10-21
HRP20160945T1 (hr) 2016-11-04
US20160228542A1 (en) 2016-08-11
EP2244734A4 (en) 2012-05-23
PL2244734T3 (pl) 2017-01-31
PT2244734T (pt) 2016-08-05
SI2244734T1 (sl) 2016-11-30
ES2585407T3 (es) 2016-10-05
US20110097361A1 (en) 2011-04-28
LT2244734T (lt) 2016-09-12
DK2244734T3 (en) 2016-08-15
ES2950396T3 (es) 2023-10-09
US20230107507A1 (en) 2023-04-06

Similar Documents

Publication Publication Date Title
CY1117948T1 (el) Μεθοδος επαγωγης ανοχης σε ενα αλλεργιογονο
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1119173T1 (el) Νεα μορια αναστολεα jnk
BRPI0918648A2 (pt) anticorpos multiespecíficos
EA201171367A1 (ru) Винилиндазолильные соединения
CY1120597T1 (el) Νεα χρηση
CY1118530T1 (el) Glyx-13 για χρηση σε μεθοδο θεραπευτικης αγωγης ανθεκτικης σε θεραπεια καταθλιψης
CY1122711T1 (el) Μεθοδος για την ενεργοποιηση και τη συζευξη βιομοριων
CY1116940T1 (el) Φλυκταινες εμπλουτισμενες σε φωσφολιπιδιο που φερουν παραγοντα ιστου εχουσες αιμοστατικες δραστικοτητες και χρησεις αυτων
CL2009001263S1 (es) Maquina de afeitar.
CY1115254T1 (el) Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
ECSP11010831A (es) Compuestos orgánicos para la cicatrización de heridas
CL2010001497A1 (es) Proceso de separacion y tratamieto de residuos por osmosis directa.
CY1117163T1 (el) Ιμιδαζοπυριδαζινες ως αναστολεις κινασης ακτ
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
CY1120877T1 (el) Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης
CY1116802T1 (el) Ετεροκυκλικες ενωσεις
CY1119413T1 (el) Μεθοδος για την παραγωγη και τη χρηση ενος συμπολυμερους νατριουχου καρβοξυμεθυλοκυτταρινης και γκοσυπολης
CL2009001363S1 (es) Pieza para maquina de afeitar.
CY1122033T1 (el) Μεθοδοι για την αυξηση του βιaιa εκπνεομενου ογκου σε ασθματικους με τη χρηση μπενραλιζουμαμπης
CY1126140T1 (el) Ναλμεφενη για τη μειωση της καταναλωσεως αλκοολης σε συγκεκριμενους πληθυσμους στοχους
CL2009001973S1 (es) Mostrador.
MY156873A (en) Novel forms of a multicyclic compound
CY1113499T1 (el) Ενωσεις θειαζολυλο-πυραζολοπυριμιδινης ως συνθετικα ενδιαμεσα και σχετικες συνθετικες διεργασιες